About
About Balaji Amines Limited
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India and internationally. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, choline chloride, mono-ethyl amine hydrochloride, and benzyl tri ethyl ammonium chloride; and pharma excipients, such as poly vinyl pyrrolidone. It also provides hotels, restaurants, and hospitality services. The company also exports its products to Europe, the United States, and Japan. Balaji Amines Limited was incorporated in 1988 and is headquartered in Hyderabad, India.
Visit company website
5 years, 5 months ago
Balaji Amines Limited is currently in a long term uptrend where the price is trading 70.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 4.9.
Balaji Amines Limited's total revenue rose by 72.4% to $4B since the same quarter in the previous year.
Its net income has increased by 220.3% to $750M since the same quarter in the previous year.
Finally, its free cash flow fell by 63.1% to $156M since the same quarter in the previous year.
Based on the above factors, Balaji Amines Limited gets an overall score of 4/5.